<i>Journal of Gastroenterology and Hepatology</i>｜Rifampicin can improve cholestasis in patients with persistent hepatocellular secretory failure

doi:10.3969/j.issn.1001-5256.2022.02.gwjpwzjj4

Volume 38 Issue 2

Feb. 2022

Turn off MathJax

Article Contents

References

Article Navigation > Journal of Clinical Hepatology > 2022 > 38(2): 396-396

PDF( 870 KB)

Journal of Gastroenterology and Hepatology｜Rifampicin can improve cholestasis in patients with persistent hepatocellular secretory failure

DOI: 10.3969/j.issn.1001-5256.2022.02.gwjpwzjj4

Published Date: 2022-02-20

Abstract

FullText(HTML)

References(0)

References

Relative Articles

[1]	Journal of Hepatology｜Genetic study of intrahepatic cholestasis of pregnancy in Chinese women unveils East Asian etiology linked to historic HBV epidemic[J]. Journal of Clinical Hepatology, 2025, 41(1): 182-182. doi: 10.12449/JCH2501.gwqkjpwzjj2
[2]	Journal of Hepatology｜Association of food insecurity with the prevalence and liver-related mortality of metabolic dysfunction-associated steatotic liver disease (MASLD)[J]. Journal of Clinical Hepatology, 2024, 40(10): 2126-2126. doi: 10.12449/JCH2410.gwqkjpwzjj3
[3]	Journal of Hepatology｜Endothelial POFUT1 controls injury-induced liver fibrosis by repressing fibrinogen synthesis[J]. Journal of Clinical Hepatology, 2024, 40(8): 1537-1537. doi: 10.12449/JCH2408.gwqkjpwzjj1
[4]	Journal of Hepatology｜Capsaicin receptor TRPV1 maintains quiescence of hepatic stellate cells in the liver via recruitment of SARM1[J]. Journal of Clinical Hepatology, 2024, 40(3): 508-508. doi: 10.12449/JCH2403.gwqkjpwzjj1
[5]	Journal of Hepatology｜Metabolic biomarkers significantly enhance the prediction of HBV-related ACLF occurrence and outcomes[J]. Journal of Clinical Hepatology, 2024, 40(2): 257-257. doi: 10.12449/JCH2402.gwqkjpwzjj1
[6]	Journal of Hepatology｜Functional cure of hepatitis B in patients with cancer undergoing immune checkpoint inhibitor therapy[J]. Journal of Clinical Hepatology, 2024, 40(11): 2237-2237. doi: 10.12449/JCH2411.gwqkjpwzjj2
[7]	Journal of Gastroenterology and Hepatology｜Novel protein C6ORF120 promotes liver fibrosis by activating hepatic stellate cells through the PI3K/Akt/mTOR pathway[J]. Journal of Clinical Hepatology, 2024, 40(5): 1049-1049. doi: 10.12449/JCH2405.gwqkjpwzjj4
[8]	Journal of Hepatology｜Baveno Ⅶ algorithm outperformed other models in ruling out high-risk varices in individuals with HBV-related cirrhosis[J]. Journal of Clinical Hepatology, 2023, 39(5): 1003-1003. doi: 10.3969/j.issn.1001-5256.2023.05.gwjpwzjj1
[9]	Journal of Hepatology｜Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated[J]. Journal of Clinical Hepatology, 2023, 39(2): 407-407. doi: 10.3969/j.issn.1001-5256.2023.02.gwjpwzjj2
[10]	Journal of Hepatology ｜ Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2023, 39(1): 151-151. doi: 10.3969/j.issn.1001-5256.2023.01.gwjpwzjj3
[11]	Journal of Gastroenterology and Hepatology｜Farnesoid X receptor is an important target for the treatment of disorders of bile acid and fatty acid metabolism in mice with nonalcoholic fatty liver disease combined with cholestasis[J]. Journal of Clinical Hepatology, 2023, 39(11): 2523-2523. doi: 10.3969/j.issn.1001-5256.2023.11.gwjpwzjj1
[12]	Journal of Hepatology｜Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis[J]. Journal of Clinical Hepatology, 2022, 38(9): 2181-2181. doi: 10.3969/j.issn.1001-5256.2022.09.gwjpwzjj5
[13]	Journal of Hepatology｜Prognostic and therapeutic significance of microbial cell-free DNA in plasma of people with acutely decompensated cirrhosis[J]. Journal of Clinical Hepatology, 2022, 38(12): 2876-2876. doi: 10.3969/j.issn.1001-5256.2022.12.gwjpwzjj3
[14]	Journal of Hepatology｜Single-cell RNA sequencing reveals the presence of an MDK-dependent immunosuppressive microenvironment in ErbB pathway-mutated gallbladder carcinoma[J]. Journal of Clinical Hepatology, 2022, 38(2): 281-281. doi: 10.3969/j.issn.1001-5256.2022.02.gwjpwzjj1
[15]	Journal of Hepatology｜Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection[J]. Journal of Clinical Hepatology, 2022, 38(12): 2727-2727. doi: 10.3969/j.issn.1001-5256.2022.12.gwjpwzjj1
[16]	Journal of Hepatology｜Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis[J]. Journal of Clinical Hepatology, 2022, 38(12): 2766-2766. doi: 10.3969/j.issn.1001-5256.2022.12.gwjpwzjj2
[17]	Journal of Hepatology｜PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2022, 38(3): 698-698. doi: 10.3969/j.issn.1001-5256.2022.3.gwjpwzjj2
[18]	Journal of Hepatology｜Interruption of bile acid uptake by hepatocytes after acetaminophen overdose ameliorates hepatotoxicity[J]. Journal of Clinical Hepatology, 2022, 38(4): 890-890. doi: 10.3969/j.issn.1001-5256.2022.04.gwjpwzjj2
[19]	Journal of Gastroenterology and Hepatology｜A high serum ferritin level increases the risk of death associated with chronic liver diseases[J]. Journal of Clinical Hepatology, 2022, 38(2): 438-438. doi: 10.3969/j.issn.1001-5256.2022.02.gwjpwzjj9
[20]	Journal of Gastroenterology and Hepatology｜Compared with chemotherapy alone as the first-line treatment, PD-1 inhibitor combined with chemotherapy can significantly improve the median progression-free survival time of patients with metastatic or recurrent cholangiocarcinoma[J]. Journal of Clinical Hepatology, 2022, 38(2): 401-401. doi: 10.3969/j.issn.1001-5256.2022.02.gwjpwzjj5

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (369) PDF downloads(69)

Journal of Gastroenterology and Hepatology｜Rifampicin can improve cholestasis in patients with persistent hepatocellular secretory failure

DOI: 10.3969/j.issn.1001-5256.2022.02.gwjpwzjj4

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Journal of Gastroenterology and Hepatology｜Rifampicin can improve cholestasis in patients with persistent hepatocellular secretory failure

DOI: 10.3969/j.issn.1001-5256.2022.02.gwjpwzjj4

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content